Here is some other vaccine news of note for this week.
> Médecins Sans Frontières is moving to block Pfizer's new Prevnar 13 patent in India. Release
> The Infectious Disease Research Institute and American Leprosy Missions started a phase 1 study for the first vaccine specifically targeting leprosy. Release
> CSL, which owns flu vaccine player Seqirus, changed its executive pay policies. Sydney Morning Herald story